Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 64 | 2021 | 565 | 5.420 |
Why?
|
Amyloid beta-Peptides | 44 | 2020 | 191 | 5.200 |
Why?
|
Amyloid Precursor Protein Secretases | 28 | 2021 | 59 | 3.820 |
Why?
|
Amyloid beta-Protein Precursor | 42 | 2020 | 115 | 3.810 |
Why?
|
Peptide Fragments | 15 | 2013 | 483 | 1.980 |
Why?
|
Aspartic Acid Endopeptidases | 18 | 2020 | 47 | 1.450 |
Why?
|
Endopeptidases | 15 | 2006 | 52 | 1.310 |
Why?
|
Brain | 26 | 2021 | 2176 | 1.130 |
Why?
|
Animals | 72 | 2022 | 20880 | 0.820 |
Why?
|
Plaque, Amyloid | 7 | 2015 | 31 | 0.710 |
Why?
|
Cholinesterase Inhibitors | 7 | 2006 | 58 | 0.680 |
Why?
|
Neuroprotective Agents | 4 | 2018 | 317 | 0.670 |
Why?
|
Lymph Nodes | 2 | 2018 | 258 | 0.670 |
Why?
|
Amyloidosis | 2 | 2018 | 48 | 0.660 |
Why?
|
Disease Models, Animal | 18 | 2018 | 2550 | 0.640 |
Why?
|
Melatonin | 1 | 2018 | 39 | 0.610 |
Why?
|
Membrane Proteins | 9 | 2006 | 617 | 0.570 |
Why?
|
CHO Cells | 10 | 2013 | 161 | 0.530 |
Why?
|
Presenilin-1 | 8 | 2015 | 28 | 0.530 |
Why?
|
Neurons | 13 | 2014 | 881 | 0.500 |
Why?
|
Retinal Pigment Epithelium | 3 | 2011 | 145 | 0.470 |
Why?
|
Neurodegenerative Diseases | 5 | 2022 | 102 | 0.460 |
Why?
|
Hippocampus | 5 | 2014 | 471 | 0.450 |
Why?
|
Humans | 72 | 2022 | 68549 | 0.450 |
Why?
|
Models, Biological | 12 | 2015 | 981 | 0.440 |
Why?
|
Gene Expression Regulation | 9 | 2021 | 1293 | 0.440 |
Why?
|
Glycosylphosphatidylinositols | 3 | 2002 | 3 | 0.430 |
Why?
|
Molecular Sequence Data | 11 | 2013 | 1446 | 0.420 |
Why?
|
Cricetinae | 9 | 2007 | 262 | 0.420 |
Why?
|
MicroRNAs | 1 | 2017 | 447 | 0.420 |
Why?
|
Enzyme Inhibitors | 4 | 2011 | 659 | 0.420 |
Why?
|
Amino Acid Sequence | 10 | 2013 | 1082 | 0.410 |
Why?
|
Memory, Short-Term | 3 | 2008 | 79 | 0.400 |
Why?
|
Nerve Growth Factor | 3 | 2011 | 54 | 0.380 |
Why?
|
Maze Learning | 4 | 2011 | 138 | 0.370 |
Why?
|
Nerve Growth Factors | 3 | 2011 | 75 | 0.370 |
Why?
|
Cholesterol, Dietary | 2 | 2008 | 22 | 0.370 |
Why?
|
Insulysin | 2 | 2007 | 3 | 0.360 |
Why?
|
Cholesterol | 3 | 2008 | 331 | 0.360 |
Why?
|
Cholinergic Fibers | 2 | 2006 | 27 | 0.360 |
Why?
|
DNA Damage | 3 | 2006 | 190 | 0.350 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 32 | 0.340 |
Why?
|
Eye Proteins | 2 | 2011 | 160 | 0.340 |
Why?
|
Eye | 1 | 2010 | 89 | 0.340 |
Why?
|
Aging | 4 | 2021 | 911 | 0.330 |
Why?
|
Mice | 25 | 2021 | 8474 | 0.330 |
Why?
|
Dietary Fats | 2 | 2008 | 103 | 0.330 |
Why?
|
Serpins | 2 | 2011 | 205 | 0.320 |
Why?
|
Cells, Cultured | 10 | 2014 | 2673 | 0.320 |
Why?
|
Physostigmine | 4 | 2013 | 14 | 0.310 |
Why?
|
Basal Nucleus of Meynert | 2 | 2006 | 6 | 0.310 |
Why?
|
Cytoplasm | 3 | 2007 | 155 | 0.300 |
Why?
|
Breast Neoplasms | 1 | 2017 | 1533 | 0.300 |
Why?
|
Polyisoprenyl Phosphates | 1 | 2007 | 8 | 0.300 |
Why?
|
Biological Evolution | 1 | 2008 | 86 | 0.300 |
Why?
|
Nerve Degeneration | 5 | 2010 | 134 | 0.300 |
Why?
|
Fatty Acids | 1 | 2008 | 222 | 0.290 |
Why?
|
Signal Transduction | 5 | 2015 | 2689 | 0.290 |
Why?
|
Technology, Pharmaceutical | 2 | 2004 | 8 | 0.290 |
Why?
|
Mice, Transgenic | 11 | 2018 | 1033 | 0.290 |
Why?
|
Butyrylcholinesterase | 2 | 2005 | 9 | 0.270 |
Why?
|
Promoter Regions, Genetic | 3 | 2008 | 614 | 0.270 |
Why?
|
Receptors, Glucagon | 4 | 2014 | 6 | 0.270 |
Why?
|
Indoles | 2 | 2021 | 146 | 0.270 |
Why?
|
Membrane Microdomains | 2 | 2003 | 32 | 0.260 |
Why?
|
Antibodies, Monoclonal | 2 | 2008 | 511 | 0.260 |
Why?
|
Cell Compartmentation | 2 | 2004 | 41 | 0.260 |
Why?
|
MAP Kinase Signaling System | 1 | 2006 | 247 | 0.260 |
Why?
|
Cricetulus | 3 | 2013 | 98 | 0.260 |
Why?
|
Diet | 2 | 2010 | 514 | 0.250 |
Why?
|
5' Untranslated Regions | 2 | 2004 | 16 | 0.250 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 9 | 2011 | 507 | 0.250 |
Why?
|
Neural Pathways | 1 | 2006 | 323 | 0.250 |
Why?
|
Memory Disorders | 4 | 2011 | 111 | 0.240 |
Why?
|
Mutation | 5 | 2015 | 1213 | 0.240 |
Why?
|
Uveitis | 1 | 2022 | 13 | 0.220 |
Why?
|
Rats | 13 | 2020 | 5300 | 0.210 |
Why?
|
Environmental Exposure | 1 | 2004 | 269 | 0.200 |
Why?
|
Acetylcholine | 4 | 2008 | 64 | 0.200 |
Why?
|
Protein Processing, Post-Translational | 4 | 2014 | 284 | 0.200 |
Why?
|
Tacrine | 2 | 1998 | 2 | 0.200 |
Why?
|
Deafness | 1 | 2022 | 64 | 0.200 |
Why?
|
Guinea Pigs | 4 | 2003 | 124 | 0.200 |
Why?
|
Oxidative Stress | 5 | 2010 | 718 | 0.200 |
Why?
|
Macular Degeneration | 2 | 2014 | 75 | 0.190 |
Why?
|
Epigenesis, Genetic | 3 | 2014 | 163 | 0.190 |
Why?
|
Metalloendopeptidases | 3 | 2014 | 67 | 0.190 |
Why?
|
Membrane Glycoproteins | 1 | 2003 | 370 | 0.190 |
Why?
|
Estrogens | 1 | 2021 | 173 | 0.180 |
Why?
|
Hearing Loss | 1 | 2022 | 154 | 0.170 |
Why?
|
Response Elements | 3 | 2021 | 29 | 0.170 |
Why?
|
Gastrointestinal Microbiome | 1 | 2021 | 121 | 0.170 |
Why?
|
Rats, Inbred F344 | 3 | 2008 | 104 | 0.170 |
Why?
|
Protease Inhibitors | 5 | 2007 | 76 | 0.170 |
Why?
|
3-Hydroxyacyl CoA Dehydrogenases | 1 | 1998 | 5 | 0.160 |
Why?
|
Protein Sorting Signals | 1 | 1998 | 11 | 0.160 |
Why?
|
Brain Chemistry | 3 | 2010 | 173 | 0.160 |
Why?
|
Enzyme Activation | 3 | 2007 | 791 | 0.150 |
Why?
|
Carrier Proteins | 2 | 1998 | 597 | 0.150 |
Why?
|
Inflammation Mediators | 2 | 2021 | 244 | 0.150 |
Why?
|
Apolipoproteins E | 2 | 2015 | 92 | 0.140 |
Why?
|
Hypercholesterolemia | 3 | 2010 | 86 | 0.140 |
Why?
|
Aflatoxins | 4 | 1989 | 6 | 0.140 |
Why?
|
Golgi Apparatus | 3 | 1993 | 75 | 0.140 |
Why?
|
Down Syndrome | 2 | 2008 | 120 | 0.140 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 369 | 0.140 |
Why?
|
Base Sequence | 9 | 2012 | 1015 | 0.140 |
Why?
|
Cell Line | 6 | 2011 | 1752 | 0.140 |
Why?
|
Endosomes | 2 | 2014 | 45 | 0.140 |
Why?
|
Heat-Shock Proteins | 1 | 1996 | 69 | 0.130 |
Why?
|
Endothelin-Converting Enzymes | 2 | 2014 | 15 | 0.130 |
Why?
|
Antibody Specificity | 2 | 2008 | 98 | 0.130 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2011 | 626 | 0.130 |
Why?
|
Cattle | 3 | 2010 | 475 | 0.130 |
Why?
|
Presenilin-2 | 1 | 2015 | 6 | 0.130 |
Why?
|
Molecular Weight | 3 | 2003 | 358 | 0.120 |
Why?
|
Cerebral Cortex | 5 | 2009 | 415 | 0.120 |
Why?
|
Pyrrolidonecarboxylic Acid | 1 | 2014 | 3 | 0.120 |
Why?
|
Solubility | 5 | 2001 | 134 | 0.120 |
Why?
|
Cell Proliferation | 2 | 2017 | 1174 | 0.120 |
Why?
|
Protein Transport | 3 | 2006 | 280 | 0.120 |
Why?
|
5' Flanking Region | 2 | 2004 | 8 | 0.120 |
Why?
|
Female | 13 | 2021 | 38021 | 0.120 |
Why?
|
Incretins | 1 | 2014 | 14 | 0.120 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2006 | 231 | 0.120 |
Why?
|
Cycloheximide | 2 | 2010 | 50 | 0.120 |
Why?
|
Proteolysis | 1 | 2014 | 97 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 756 | 0.110 |
Why?
|
Macromolecular Substances | 2 | 2003 | 122 | 0.110 |
Why?
|
Plasminogen Inactivators | 1 | 1992 | 1 | 0.110 |
Why?
|
Organelles | 1 | 1992 | 18 | 0.110 |
Why?
|
Transcription Factors | 3 | 2006 | 753 | 0.110 |
Why?
|
Amyloidogenic Proteins | 1 | 2012 | 4 | 0.100 |
Why?
|
Mutagens | 2 | 1989 | 18 | 0.100 |
Why?
|
Gene-Environment Interaction | 1 | 2012 | 31 | 0.100 |
Why?
|
Cell Death | 4 | 2009 | 329 | 0.100 |
Why?
|
Mutant Proteins | 1 | 2012 | 45 | 0.100 |
Why?
|
Age Factors | 4 | 2012 | 1860 | 0.100 |
Why?
|
Peptide Hydrolases | 2 | 2003 | 82 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2011 | 219 | 0.100 |
Why?
|
Environment | 3 | 2012 | 115 | 0.100 |
Why?
|
Male | 16 | 2021 | 37283 | 0.100 |
Why?
|
PC12 Cells | 6 | 2004 | 36 | 0.100 |
Why?
|
Biological Assay | 1 | 2011 | 88 | 0.100 |
Why?
|
Retina | 2 | 2010 | 252 | 0.100 |
Why?
|
Risk Factors | 5 | 2012 | 5720 | 0.090 |
Why?
|
Brain Injuries | 1 | 2014 | 268 | 0.090 |
Why?
|
Mitochondria | 2 | 2010 | 643 | 0.090 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2010 | 4 | 0.090 |
Why?
|
Base Composition | 4 | 2004 | 22 | 0.090 |
Why?
|
Axonal Transport | 2 | 2006 | 9 | 0.090 |
Why?
|
Homocysteine | 2 | 2010 | 26 | 0.090 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2010 | 32 | 0.090 |
Why?
|
Body Fluids | 1 | 2010 | 41 | 0.090 |
Why?
|
Nutrition Therapy | 1 | 2010 | 21 | 0.090 |
Why?
|
Glucagon-Like Peptide-1 Receptor | 4 | 2014 | 20 | 0.090 |
Why?
|
Vitreous Body | 1 | 2010 | 26 | 0.090 |
Why?
|
Cholecalciferol | 1 | 2011 | 143 | 0.090 |
Why?
|
Drug Discovery | 1 | 2011 | 94 | 0.090 |
Why?
|
Aqueous Humor | 1 | 2010 | 51 | 0.090 |
Why?
|
Longevity | 1 | 2010 | 59 | 0.090 |
Why?
|
Permeability | 1 | 2009 | 131 | 0.080 |
Why?
|
Mice, Knockout | 5 | 2021 | 1692 | 0.080 |
Why?
|
Central Nervous System | 1 | 2010 | 107 | 0.080 |
Why?
|
Epithelial Cells | 1 | 2011 | 431 | 0.080 |
Why?
|
Tocopherols | 1 | 2008 | 7 | 0.080 |
Why?
|
Chelation Therapy | 1 | 2009 | 17 | 0.080 |
Why?
|
Cytoprotection | 1 | 2009 | 39 | 0.080 |
Why?
|
Guanidines | 1 | 1988 | 32 | 0.080 |
Why?
|
Immunohistochemistry | 5 | 2006 | 1174 | 0.080 |
Why?
|
Aluminum | 1 | 2008 | 21 | 0.080 |
Why?
|
Chelating Agents | 1 | 2009 | 47 | 0.080 |
Why?
|
Reversal Learning | 1 | 2008 | 7 | 0.080 |
Why?
|
Mice, Inbred BALB C | 1 | 2010 | 532 | 0.080 |
Why?
|
Coconut Oil | 1 | 2008 | 3 | 0.080 |
Why?
|
Tumor Cells, Cultured | 5 | 2006 | 852 | 0.080 |
Why?
|
Neurofibrillary Tangles | 1 | 2008 | 8 | 0.080 |
Why?
|
Hybridomas | 1 | 2008 | 25 | 0.080 |
Why?
|
Microscopy, Video | 1 | 2008 | 27 | 0.080 |
Why?
|
Immunoglobulin Isotypes | 1 | 2008 | 28 | 0.080 |
Why?
|
DNA | 4 | 1990 | 597 | 0.080 |
Why?
|
Orientation | 1 | 2008 | 31 | 0.080 |
Why?
|
Plant Oils | 1 | 2008 | 31 | 0.080 |
Why?
|
Encephalitis | 1 | 2008 | 43 | 0.080 |
Why?
|
DNA, Z-Form | 1 | 2008 | 1 | 0.080 |
Why?
|
Protein Precursors | 2 | 2003 | 105 | 0.080 |
Why?
|
Blotting, Western | 5 | 2006 | 954 | 0.080 |
Why?
|
Metals | 1 | 2009 | 100 | 0.080 |
Why?
|
Cholesterol, HDL | 1 | 2008 | 112 | 0.080 |
Why?
|
Venoms | 2 | 2009 | 6 | 0.080 |
Why?
|
Vitamins | 1 | 2008 | 134 | 0.080 |
Why?
|
Silver Staining | 1 | 2007 | 11 | 0.080 |
Why?
|
Triglycerides | 1 | 2008 | 184 | 0.080 |
Why?
|
Swine | 1 | 2009 | 672 | 0.080 |
Why?
|
Down-Regulation | 2 | 2006 | 447 | 0.080 |
Why?
|
Cell Line, Tumor | 4 | 2006 | 1851 | 0.080 |
Why?
|
Fluoresceins | 1 | 2007 | 31 | 0.080 |
Why?
|
Substrate Specificity | 1 | 2007 | 234 | 0.070 |
Why?
|
Receptor, trkA | 1 | 2006 | 13 | 0.070 |
Why?
|
Lovastatin | 1 | 2007 | 78 | 0.070 |
Why?
|
Cell Adhesion Molecules, Neuron-Glia | 1 | 2006 | 1 | 0.070 |
Why?
|
Autolysis | 1 | 2006 | 2 | 0.070 |
Why?
|
Genes, cdc | 1 | 2006 | 5 | 0.070 |
Why?
|
Cognition Disorders | 1 | 2010 | 342 | 0.070 |
Why?
|
Hydrolysis | 2 | 1999 | 144 | 0.070 |
Why?
|
Neuroblastoma | 3 | 2006 | 109 | 0.070 |
Why?
|
Dopamine | 1 | 2009 | 474 | 0.070 |
Why?
|
Immunotherapy | 1 | 2008 | 215 | 0.070 |
Why?
|
Fluorescent Dyes | 1 | 2007 | 191 | 0.070 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 175 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2011 | 1745 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2008 | 689 | 0.070 |
Why?
|
Parkinson Disease | 1 | 2009 | 272 | 0.070 |
Why?
|
Binding Sites | 2 | 2004 | 631 | 0.070 |
Why?
|
Molecular Biology | 2 | 2004 | 31 | 0.070 |
Why?
|
Amyloid | 1 | 2006 | 39 | 0.070 |
Why?
|
Introns | 2 | 2004 | 68 | 0.070 |
Why?
|
Hot Temperature | 2 | 1996 | 152 | 0.060 |
Why?
|
Mice, Inbred C57BL | 5 | 2012 | 2791 | 0.060 |
Why?
|
Inflammation | 3 | 2022 | 1030 | 0.060 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2004 | 27 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2006 | 331 | 0.060 |
Why?
|
Stereoisomerism | 3 | 2013 | 169 | 0.060 |
Why?
|
Steroid Hydroxylases | 1 | 2004 | 19 | 0.060 |
Why?
|
Consensus Sequence | 1 | 2004 | 20 | 0.060 |
Why?
|
Transcription Initiation Site | 1 | 2004 | 11 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2021 | 562 | 0.060 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2004 | 32 | 0.060 |
Why?
|
Restriction Mapping | 1 | 2004 | 85 | 0.060 |
Why?
|
Apolipoproteins | 1 | 2004 | 51 | 0.060 |
Why?
|
Secretory Vesicles | 1 | 2004 | 6 | 0.060 |
Why?
|
ADAM17 Protein | 1 | 2004 | 28 | 0.060 |
Why?
|
Phorbol Esters | 1 | 2004 | 37 | 0.060 |
Why?
|
L-Lactate Dehydrogenase | 2 | 2006 | 67 | 0.060 |
Why?
|
Exons | 1 | 2004 | 122 | 0.060 |
Why?
|
Thalidomide | 1 | 2004 | 24 | 0.060 |
Why?
|
Cues | 1 | 2008 | 654 | 0.060 |
Why?
|
Learning | 1 | 2005 | 186 | 0.060 |
Why?
|
Acetylcholinesterase | 2 | 2002 | 19 | 0.060 |
Why?
|
ADAM Proteins | 1 | 2004 | 53 | 0.060 |
Why?
|
Cloning, Molecular | 1 | 2004 | 357 | 0.060 |
Why?
|
Glucagon | 1 | 2003 | 22 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2010 | 805 | 0.060 |
Why?
|
Hydroxamic Acids | 1 | 2004 | 84 | 0.060 |
Why?
|
Dipeptides | 1 | 2004 | 89 | 0.060 |
Why?
|
Cell Survival | 4 | 2014 | 901 | 0.060 |
Why?
|
Drug Design | 1 | 2004 | 107 | 0.060 |
Why?
|
Genomics | 1 | 2004 | 168 | 0.050 |
Why?
|
Protein Subunits | 1 | 2003 | 99 | 0.050 |
Why?
|
Estrogen Replacement Therapy | 1 | 2003 | 38 | 0.050 |
Why?
|
Autopsy | 1 | 2002 | 56 | 0.050 |
Why?
|
Postmenopause | 1 | 2003 | 92 | 0.050 |
Why?
|
Prefrontal Cortex | 1 | 2008 | 639 | 0.050 |
Why?
|
Protein Kinase C | 2 | 2004 | 270 | 0.050 |
Why?
|
Dependovirus | 1 | 2022 | 34 | 0.050 |
Why?
|
Transduction, Genetic | 1 | 2022 | 81 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2001 | 618 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2004 | 307 | 0.050 |
Why?
|
Biology | 1 | 2002 | 14 | 0.050 |
Why?
|
T-Lymphocyte Subsets | 1 | 2022 | 126 | 0.050 |
Why?
|
Estradiol | 1 | 2003 | 176 | 0.050 |
Why?
|
tau Proteins | 2 | 2014 | 61 | 0.050 |
Why?
|
Culture Media, Conditioned | 2 | 1998 | 78 | 0.050 |
Why?
|
Gene Transfer Techniques | 1 | 2022 | 173 | 0.050 |
Why?
|
Genetic Vectors | 1 | 2022 | 311 | 0.050 |
Why?
|
Transfection | 5 | 2001 | 782 | 0.050 |
Why?
|
Phenanthrolines | 1 | 2001 | 5 | 0.050 |
Why?
|
Pepstatins | 1 | 2001 | 3 | 0.050 |
Why?
|
Estrogen Receptor alpha | 1 | 2021 | 65 | 0.050 |
Why?
|
Neuroprotection | 1 | 2021 | 28 | 0.050 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 199 | 0.050 |
Why?
|
Detergents | 1 | 2001 | 34 | 0.050 |
Why?
|
Drug Delivery Systems | 1 | 2003 | 236 | 0.050 |
Why?
|
Subcellular Fractions | 1 | 2001 | 92 | 0.050 |
Why?
|
Androstadienes | 1 | 2000 | 41 | 0.050 |
Why?
|
HEK293 Cells | 1 | 2021 | 326 | 0.050 |
Why?
|
Genetic Therapy | 1 | 2022 | 291 | 0.050 |
Why?
|
Caspases | 1 | 2001 | 194 | 0.050 |
Why?
|
Analysis of Variance | 3 | 2008 | 1040 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2004 | 848 | 0.050 |
Why?
|
HeLa Cells | 2 | 1999 | 237 | 0.050 |
Why?
|
Rivastigmine | 1 | 2020 | 6 | 0.040 |
Why?
|
Caspase 3 | 1 | 2001 | 233 | 0.040 |
Why?
|
Sulfur Radioisotopes | 3 | 1999 | 11 | 0.040 |
Why?
|
RNA, Antisense | 1 | 1999 | 25 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2004 | 514 | 0.040 |
Why?
|
Phosphoinositide Phospholipase C | 1 | 1999 | 1 | 0.040 |
Why?
|
Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1999 | 6 | 0.040 |
Why?
|
Intracellular Membranes | 1 | 1999 | 86 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2021 | 295 | 0.040 |
Why?
|
Apoptosis | 1 | 2006 | 1641 | 0.040 |
Why?
|
Type C Phospholipases | 1 | 1999 | 67 | 0.040 |
Why?
|
Endoplasmic Reticulum | 1 | 1999 | 148 | 0.040 |
Why?
|
Drosophila | 1 | 1998 | 37 | 0.040 |
Why?
|
Biological Transport | 1 | 1998 | 210 | 0.040 |
Why?
|
Microbodies | 1 | 1998 | 60 | 0.040 |
Why?
|
Chromaffin Granules | 1 | 1998 | 2 | 0.040 |
Why?
|
Recombinant Proteins | 3 | 2012 | 742 | 0.040 |
Why?
|
Aged | 4 | 2014 | 14842 | 0.040 |
Why?
|
Cell Membrane | 3 | 1998 | 524 | 0.040 |
Why?
|
Cell Fractionation | 2 | 1999 | 34 | 0.040 |
Why?
|
DNA Replication | 3 | 1989 | 167 | 0.040 |
Why?
|
Nerve Tissue Proteins | 3 | 2006 | 290 | 0.040 |
Why?
|
Leupeptins | 1 | 1997 | 23 | 0.040 |
Why?
|
Iodine Radioisotopes | 2 | 1998 | 119 | 0.040 |
Why?
|
Kinetics | 2 | 2003 | 1047 | 0.040 |
Why?
|
Reactive Oxygen Species | 2 | 2010 | 499 | 0.040 |
Why?
|
Aflatoxin B1 | 4 | 1989 | 5 | 0.040 |
Why?
|
Stroke | 1 | 2009 | 2162 | 0.030 |
Why?
|
Software | 1 | 1998 | 418 | 0.030 |
Why?
|
Shock | 1 | 1995 | 28 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 3 | 2005 | 2083 | 0.030 |
Why?
|
Lysosomes | 2 | 1993 | 136 | 0.030 |
Why?
|
Up-Regulation | 2 | 2008 | 682 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2009 | 7028 | 0.030 |
Why?
|
Immunoblotting | 3 | 2004 | 254 | 0.030 |
Why?
|
Endocytosis | 1 | 1995 | 113 | 0.030 |
Why?
|
Cholera Toxin | 1 | 1994 | 30 | 0.030 |
Why?
|
DNA, Viral | 3 | 1989 | 114 | 0.030 |
Why?
|
Receptors, Lipoxin | 1 | 2014 | 3 | 0.030 |
Why?
|
Receptors, Formyl Peptide | 1 | 2014 | 4 | 0.030 |
Why?
|
Lipoxins | 1 | 2014 | 4 | 0.030 |
Why?
|
Docosahexaenoic Acids | 1 | 2014 | 12 | 0.030 |
Why?
|
Lipoxygenase | 1 | 2014 | 13 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1994 | 138 | 0.030 |
Why?
|
Antioxidants | 1 | 1996 | 304 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 1995 | 376 | 0.030 |
Why?
|
Nuclear Proteins | 2 | 2006 | 271 | 0.030 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 1993 | 36 | 0.030 |
Why?
|
Peptides | 2 | 2009 | 455 | 0.030 |
Why?
|
Protease Nexins | 1 | 1992 | 8 | 0.030 |
Why?
|
Proteoglycans | 1 | 1993 | 103 | 0.030 |
Why?
|
Mice, Inbred Strains | 2 | 2003 | 181 | 0.030 |
Why?
|
Neurofibrils | 1 | 1992 | 2 | 0.030 |
Why?
|
Receptors, Muscarinic | 1 | 2013 | 44 | 0.030 |
Why?
|
alpha-Synuclein | 1 | 2013 | 28 | 0.030 |
Why?
|
Sulfates | 1 | 1992 | 28 | 0.030 |
Why?
|
Polymorphism, Genetic | 2 | 2004 | 301 | 0.030 |
Why?
|
Receptors, Nicotinic | 1 | 2013 | 41 | 0.030 |
Why?
|
Choline O-Acetyltransferase | 2 | 2008 | 30 | 0.030 |
Why?
|
Aprotinin | 1 | 1992 | 55 | 0.030 |
Why?
|
Escherichia coli | 3 | 1989 | 368 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2013 | 88 | 0.030 |
Why?
|
Chromosomes, Artificial, Yeast | 1 | 2012 | 16 | 0.030 |
Why?
|
Receptors, Notch | 1 | 2012 | 15 | 0.030 |
Why?
|
Plasmids | 2 | 1994 | 258 | 0.030 |
Why?
|
Gene Knock-In Techniques | 1 | 2012 | 35 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2006 | 1663 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2012 | 166 | 0.030 |
Why?
|
Tight Junctions | 1 | 2011 | 25 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2012 | 137 | 0.030 |
Why?
|
Time Factors | 2 | 2014 | 4655 | 0.030 |
Why?
|
DNA, Complementary | 1 | 2012 | 251 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 1992 | 248 | 0.020 |
Why?
|
Substantia Innominata | 1 | 1991 | 3 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2011 | 200 | 0.020 |
Why?
|
Tretinoin | 1 | 2011 | 92 | 0.020 |
Why?
|
NFI Transcription Factors | 1 | 2011 | 6 | 0.020 |
Why?
|
N-Methylaspartate | 1 | 1991 | 59 | 0.020 |
Why?
|
Retinaldehyde | 1 | 2011 | 115 | 0.020 |
Why?
|
Cognitive Dysfunction | 1 | 2014 | 176 | 0.020 |
Why?
|
Viral Proteins | 1 | 2011 | 149 | 0.020 |
Why?
|
Rodentia | 1 | 2010 | 27 | 0.020 |
Why?
|
Electron Transport | 1 | 2010 | 37 | 0.020 |
Why?
|
Receptors, Lipoprotein | 1 | 2010 | 11 | 0.020 |
Why?
|
Oxidative Phosphorylation | 1 | 2010 | 54 | 0.020 |
Why?
|
Spain | 1 | 2010 | 34 | 0.020 |
Why?
|
Avitaminosis | 1 | 2010 | 3 | 0.020 |
Why?
|
Bone and Bones | 1 | 2011 | 145 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2004 | 700 | 0.020 |
Why?
|
Protective Agents | 1 | 2010 | 36 | 0.020 |
Why?
|
Vitamin E | 1 | 2010 | 55 | 0.020 |
Why?
|
Receptors, Dopamine | 1 | 1990 | 119 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2014 | 1549 | 0.020 |
Why?
|
Point Mutation | 1 | 2010 | 97 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2010 | 161 | 0.020 |
Why?
|
Bacteriophages | 1 | 1989 | 24 | 0.020 |
Why?
|
Acetaldehyde | 1 | 1989 | 18 | 0.020 |
Why?
|
Middle Aged | 3 | 2014 | 21119 | 0.020 |
Why?
|
Guanidine | 1 | 1988 | 7 | 0.020 |
Why?
|
Chromosomes, Mammalian | 1 | 2008 | 8 | 0.020 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2009 | 22 | 0.020 |
Why?
|
Energy Intake | 1 | 2010 | 123 | 0.020 |
Why?
|
Mice, Neurologic Mutants | 1 | 2008 | 23 | 0.020 |
Why?
|
DNA, Single-Stranded | 2 | 1987 | 41 | 0.020 |
Why?
|
Calbindins | 1 | 2008 | 23 | 0.020 |
Why?
|
S100 Calcium Binding Protein G | 1 | 2008 | 21 | 0.020 |
Why?
|
Mesencephalon | 1 | 2009 | 41 | 0.020 |
Why?
|
Prosencephalon | 1 | 2008 | 38 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2008 | 134 | 0.020 |
Why?
|
Trisomy | 1 | 2008 | 47 | 0.020 |
Why?
|
beta-Galactosidase | 1 | 1988 | 88 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2009 | 92 | 0.020 |
Why?
|
Brain Infarction | 1 | 2009 | 54 | 0.020 |
Why?
|
Discrimination Learning | 1 | 2008 | 45 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2009 | 176 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2010 | 222 | 0.020 |
Why?
|
Biomarkers | 1 | 2014 | 1593 | 0.020 |
Why?
|
Receptors, LDL | 1 | 2008 | 72 | 0.020 |
Why?
|
Odorants | 1 | 2008 | 52 | 0.020 |
Why?
|
Rabbits | 1 | 2008 | 509 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2008 | 213 | 0.020 |
Why?
|
YY1 Transcription Factor | 1 | 2006 | 6 | 0.020 |
Why?
|
Phosphorylation | 1 | 2010 | 1200 | 0.020 |
Why?
|
Linear Models | 1 | 2008 | 521 | 0.020 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2006 | 39 | 0.020 |
Why?
|
Cystathionine beta-Synthase | 1 | 2006 | 1 | 0.020 |
Why?
|
Extracellular Space | 1 | 2006 | 121 | 0.020 |
Why?
|
Cognition | 1 | 2010 | 512 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2006 | 137 | 0.020 |
Why?
|
Incidence | 1 | 2010 | 1582 | 0.020 |
Why?
|
Tartrates | 1 | 2005 | 2 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2006 | 189 | 0.020 |
Why?
|
Cell Count | 1 | 2006 | 248 | 0.020 |
Why?
|
Serine | 1 | 2005 | 99 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2006 | 420 | 0.020 |
Why?
|
Tumor Necrosis Factor Decoy Receptors | 1 | 2004 | 1 | 0.020 |
Why?
|
Precipitin Tests | 2 | 1995 | 88 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2006 | 492 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2005 | 371 | 0.020 |
Why?
|
Cholesterol 24-Hydroxylase | 1 | 2004 | 1 | 0.020 |
Why?
|
Hydroxycholesterols | 1 | 2004 | 10 | 0.020 |
Why?
|
Orphan Nuclear Receptors | 1 | 2004 | 5 | 0.020 |
Why?
|
Cholestanetriol 26-Monooxygenase | 1 | 2004 | 8 | 0.020 |
Why?
|
Liver X Receptors | 1 | 2004 | 8 | 0.020 |
Why?
|
Neurobiology | 1 | 2004 | 9 | 0.020 |
Why?
|
Receptors, Steroid | 1 | 2004 | 13 | 0.020 |
Why?
|
Benzothiazoles | 1 | 2004 | 14 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2010 | 7268 | 0.020 |
Why?
|
Transcription Factor AP-2 | 1 | 2004 | 9 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2004 | 73 | 0.010 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2004 | 60 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2011 | 1070 | 0.010 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 66 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2004 | 89 | 0.010 |
Why?
|
Gene Frequency | 1 | 2004 | 207 | 0.010 |
Why?
|
Cytokines | 1 | 2008 | 866 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2004 | 191 | 0.010 |
Why?
|
Organ Specificity | 1 | 2004 | 167 | 0.010 |
Why?
|
Thiazoles | 1 | 2004 | 95 | 0.010 |
Why?
|
Models, Neurological | 1 | 2004 | 136 | 0.010 |
Why?
|
Oligodendroglia | 1 | 2004 | 107 | 0.010 |
Why?
|
Adenoviridae | 1 | 2004 | 295 | 0.010 |
Why?
|
Models, Genetic | 1 | 2004 | 161 | 0.010 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2003 | 17 | 0.010 |
Why?
|
Glioma | 2 | 1995 | 140 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2010 | 3256 | 0.010 |
Why?
|
Administration, Cutaneous | 1 | 2003 | 56 | 0.010 |
Why?
|
DNA Primers | 1 | 2003 | 302 | 0.010 |
Why?
|
Fetus | 1 | 2003 | 157 | 0.010 |
Why?
|
Sex Factors | 1 | 2006 | 1265 | 0.010 |
Why?
|
Kidney | 2 | 1999 | 945 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2002 | 322 | 0.010 |
Why?
|
Astrocytes | 1 | 2004 | 270 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2003 | 567 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 710 | 0.010 |
Why?
|
Iron | 1 | 2003 | 197 | 0.010 |
Why?
|
Sequence Analysis, Protein | 1 | 2001 | 16 | 0.010 |
Why?
|
Cell-Free System | 1 | 2000 | 43 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 2222 | 0.010 |
Why?
|
Genotype | 1 | 2003 | 785 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2010 | 1085 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2001 | 80 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2001 | 381 | 0.010 |
Why?
|
Oligopeptides | 1 | 2000 | 152 | 0.010 |
Why?
|
Uridine Diphosphate N-Acetylglucosamine | 1 | 1999 | 2 | 0.010 |
Why?
|
Radioisotope Dilution Technique | 1 | 1999 | 14 | 0.010 |
Why?
|
Glucosamine | 1 | 1999 | 8 | 0.010 |
Why?
|
Inositol | 1 | 1999 | 11 | 0.010 |
Why?
|
Mannose | 1 | 1999 | 9 | 0.010 |
Why?
|
Choline | 1 | 1999 | 14 | 0.010 |
Why?
|
Carbohydrate Sequence | 1 | 1999 | 45 | 0.010 |
Why?
|
K562 Cells | 1 | 1999 | 44 | 0.010 |
Why?
|
Tritium | 1 | 1999 | 101 | 0.010 |
Why?
|
Administration, Oral | 1 | 2000 | 411 | 0.010 |
Why?
|
Tubulin | 1 | 1999 | 60 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2000 | 223 | 0.010 |
Why?
|
Doxycycline | 1 | 1999 | 49 | 0.010 |
Why?
|
Cysteine | 1 | 1999 | 112 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2003 | 1738 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 1999 | 149 | 0.010 |
Why?
|
Models, Chemical | 1 | 1999 | 155 | 0.010 |
Why?
|
Azirines | 1 | 1998 | 1 | 0.010 |
Why?
|
Adrenal Medulla | 1 | 1998 | 5 | 0.010 |
Why?
|
Photoaffinity Labels | 1 | 1998 | 7 | 0.010 |
Why?
|
Biotinylation | 1 | 1998 | 27 | 0.010 |
Why?
|
Trypsin | 1 | 1998 | 64 | 0.010 |
Why?
|
Cross-Linking Reagents | 1 | 1998 | 80 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2003 | 1851 | 0.010 |
Why?
|
Parasympathomimetics | 1 | 1997 | 13 | 0.010 |
Why?
|
Carbachol | 1 | 1997 | 34 | 0.010 |
Why?
|
Nucleic Acid Conformation | 2 | 1987 | 92 | 0.010 |
Why?
|
Methylamines | 1 | 1995 | 4 | 0.010 |
Why?
|
Chloroquine | 1 | 1995 | 21 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 1995 | 71 | 0.010 |
Why?
|
Prospective Studies | 1 | 2003 | 3703 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1995 | 149 | 0.010 |
Why?
|
Cold Temperature | 1 | 1995 | 90 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1995 | 282 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1995 | 282 | 0.010 |
Why?
|
Placenta | 1 | 1995 | 101 | 0.010 |
Why?
|
Mutagenesis | 1 | 1994 | 60 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2003 | 4843 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 1994 | 231 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1991 | 79 | 0.010 |
Why?
|
Polyribosomes | 1 | 1991 | 24 | 0.010 |
Why?
|
Methionine | 1 | 1991 | 36 | 0.010 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 1991 | 50 | 0.010 |
Why?
|
Autoradiography | 1 | 1991 | 94 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1991 | 532 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1991 | 181 | 0.010 |
Why?
|
Poly A | 1 | 1990 | 14 | 0.010 |
Why?
|
Pituitary Gland | 1 | 1990 | 29 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 1994 | 371 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1990 | 95 | 0.010 |
Why?
|
Receptors, Dopamine D2 | 1 | 1990 | 109 | 0.010 |
Why?
|
Nucleic Acid Heteroduplexes | 1 | 1989 | 7 | 0.010 |
Why?
|
Cytosine Nucleotides | 1 | 1989 | 2 | 0.010 |
Why?
|
Coliphages | 1 | 1989 | 6 | 0.010 |
Why?
|
Cell Differentiation | 1 | 1993 | 1034 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 1989 | 159 | 0.010 |
Why?
|
Guanine | 1 | 1987 | 21 | 0.000 |
Why?
|
Manganese | 1 | 1987 | 26 | 0.000 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1987 | 37 | 0.000 |
Why?
|
Magnesium | 1 | 1987 | 110 | 0.000 |
Why?
|
DNA, Bacterial | 1 | 1987 | 150 | 0.000 |
Why?
|
Templates, Genetic | 1 | 1985 | 9 | 0.000 |
Why?
|
Chemical Phenomena | 1 | 1985 | 62 | 0.000 |
Why?
|
Chemistry | 1 | 1985 | 45 | 0.000 |
Why?
|
Epoxy Compounds | 1 | 1985 | 20 | 0.000 |
Why?
|
Hydrogen Bonding | 1 | 1985 | 66 | 0.000 |
Why?
|